Scholarlink

Background <p>Long-term survival can be achieved in patients with localized prostate cancer (PCa). Therefore, maintenance of postoperative quality of life (QOL) and treatment satisfaction are important. Although longitudinal changes in disease-specific QOL are reported, there are few studies investigating which factors longitudinally affect treatment satisfaction in patients who undergo robot-assisted radical prostatectomy (RARP). Therefore, we examined the factors associated with treatment satisfaction over the first 12 months postoperatively based on an assessment using a patient-reported questionnaire.</p> Methods <p>Of the 612 consecutive patients who underwent RARP, 408 patients were enrolled in this study and divided into a satisfied group and a non-satisfied group at every evaluation timepoint. Multivariate logistic regression analysis was conducted to clarify factors affecting the postoperative treatment satisfaction between the two groups.</p> Results <p>Multivariate logistic regression analysis revealed that factors relating to treatment satisfaction had longitudinally changed. Urinary bother (UB) (odds ratio (OR) = 1.023; <i>p</i> = 0.008), and sexual function (SF) (OR = 0.941; <i>p</i> = 0.004) were the significant factors associated with treatment satisfaction at 1 month postoperatively; UB (OR = 1.040; <i>p</i> = 0.001) and sexual bother (SB) (OR = 1.019; <i>p</i> &lt; 0.001) at 3 months; urinary function (UF) (OR = 1.027; <i>p</i> = 0.008), UB (OR = 1.035; <i>p</i> = 0.011), SB (OR = 1.013; <i>p</i> = 0.009), and hormonal bother (HB) (OR = 1.065; <i>p</i> = 0.023) at 6 months; UF (OR = 1.026; <i>p</i> = 0.008), UB (OR = 1.030; <i>p</i> = 0.029), and SB (OR = 1.014; <i>p</i> = 0.004) at 9 months; UF (OR = 1.024; <i>p</i> = 0.002) at 12 months.</p> Conclusions <p>Treatment satisfaction in patients who underwent RARP changed over time. Our results suggest that giving sufficient information before treatment choice is both important and useful for patients’ decision-making, leading to improved patient QOL.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Longitudinal changes in factors affecting postoperative patient satisfaction after robot-assisted radical prostatectomy: an assessment using a patient-reported questionnaire

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年1月23日

查看全文
  • Soichiro Ogawa,
  • Kei Yaginuma,
  • Yuki Harigane,
  • Shunta Makabe,
  • Hitomi Imai,
  • Satoru Meguro,
  • Ryo Tanji,
  • Akifumi Onagi,
  • Ruriko Honda-Takinami,
  • Kanako Matsuoka,
  • Seiji Hoshi,
  • Junya Hata,
  • Yuichi Sato,
  • Hidenori Akaihata,
  • Masao Kataoka,
  • Motohide Uemura,
  • Yoshiyuki Kojima

摘要

Background

Long-term survival can be achieved in patients with localized prostate cancer (PCa). Therefore, maintenance of postoperative quality of life (QOL) and treatment satisfaction are important. Although longitudinal changes in disease-specific QOL are reported, there are few studies investigating which factors longitudinally affect treatment satisfaction in patients who undergo robot-assisted radical prostatectomy (RARP). Therefore, we examined the factors associated with treatment satisfaction over the first 12 months postoperatively based on an assessment using a patient-reported questionnaire.

Methods

Of the 612 consecutive patients who underwent RARP, 408 patients were enrolled in this study and divided into a satisfied group and a non-satisfied group at every evaluation timepoint. Multivariate logistic regression analysis was conducted to clarify factors affecting the postoperative treatment satisfaction between the two groups.

Results

Multivariate logistic regression analysis revealed that factors relating to treatment satisfaction had longitudinally changed. Urinary bother (UB) (odds ratio (OR) = 1.023; p = 0.008), and sexual function (SF) (OR = 0.941; p = 0.004) were the significant factors associated with treatment satisfaction at 1 month postoperatively; UB (OR = 1.040; p = 0.001) and sexual bother (SB) (OR = 1.019; p < 0.001) at 3 months; urinary function (UF) (OR = 1.027; p = 0.008), UB (OR = 1.035; p = 0.011), SB (OR = 1.013; p = 0.009), and hormonal bother (HB) (OR = 1.065; p = 0.023) at 6 months; UF (OR = 1.026; p = 0.008), UB (OR = 1.030; p = 0.029), and SB (OR = 1.014; p = 0.004) at 9 months; UF (OR = 1.024; p = 0.002) at 12 months.

Conclusions

Treatment satisfaction in patients who underwent RARP changed over time. Our results suggest that giving sufficient information before treatment choice is both important and useful for patients’ decision-making, leading to improved patient QOL.